OSR Holdings Enters Material Definitive Agreement
Ticker: OSRHW · Form: 8-K · Filed: Aug 20, 2025 · CIK: 1840425
| Field | Detail |
|---|---|
| Company | Osr Holdings, Inc. (OSRHW) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50, $400,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
OSR Holdings signed a big deal on Aug 10th. Details to come.
AI Summary
OSR Holdings, Inc. filed an 8-K on August 20, 2025, reporting an entry into a material definitive agreement on August 10, 2025. The company, formerly known as Bellevue Life Sciences Acquisition Corp., is incorporated in Delaware and operates in the surgical and medical instruments sector.
Why It Matters
This filing indicates a significant new contract or partnership for OSR Holdings, which could impact its future revenue and operations.
Risk Assessment
Risk Level: medium — The filing reports a material definitive agreement, which could carry significant financial implications and operational changes for the company.
Key Numbers
- 001-41390 — Commission File Number (SEC File Number for OSR Holdings, Inc.)
- 84-5052822 — IRS Employer Identification Number (Tax identification for OSR Holdings, Inc.)
Key Players & Entities
- OSR Holdings, Inc. (company) — Registrant
- Bellevue Life Sciences Acquisition Corp. (company) — Former company name
- August 10, 2025 (date) — Date of earliest event reported
- August 20, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by OSR Holdings, Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on August 10, 2025.
When was OSR Holdings, Inc. formerly known as Bellevue Life Sciences Acquisition Corp.?
The date of the name change from Bellevue Life Sciences Acquisition Corp. to OSR Holdings, Inc. was January 13, 2021.
What is OSR Holdings, Inc.'s primary business sector?
OSR Holdings, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, with SIC code 3841.
Where is OSR Holdings, Inc. headquartered?
OSR Holdings, Inc. is headquartered at 10900 NE 4TH STREET, SUITE 2300, BELLEVUE, WA 98004.
What is the par value per share for OSR Holdings, Inc. common stock?
The par value per share for OSR Holdings, Inc. common stock is $0.0001.
Filing Stats: 834 words · 3 min read · ~3 pages · Grade level 10.4 · Accepted 2025-08-20 17:29:45
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share OSRH The Nasdaq Stock Mar
- $11.50 — of common stock at an exercise price of $11.50 per share OSRHW The Nasdaq Stock Ma
- $400,000 — to liquidated damages in the amount of $400,000, payable immediately in cash. For the a
Filing Documents
- ea0254096-8k_osrholdings.htm (8-K) — 35KB
- ea025409601ex10-1_osrhold.htm (EX-10.1) — 13KB
- ea025409601ex10-2_osrhold.htm (EX-10.2) — 13KB
- 0001213900-25-079053.txt ( ) — 278KB
- osrh-20250810.xsd (EX-101.SCH) — 4KB
- osrh-20250810_def.xml (EX-101.DEF) — 26KB
- osrh-20250810_lab.xml (EX-101.LAB) — 36KB
- osrh-20250810_pre.xml (EX-101.PRE) — 25KB
- ea0254096-8k_osrholdings_htm.xml (XML) — 6KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. On August 10, 2025, OSR Holdings, Inc. (the "Company") entered into the following amendment agreements with White Lion Capital, LLC, dba White Lion GBM Innovation Fund ("White Lion"): Amendment No. 1 to Note Purchase Agreement The Company and White Lion entered into Amendment No. 1 to the Note Purchase Agreement, originally dated May 6, 2025. The amendment replaces Section 5(f) of the Note Purchase Agreement in its entirety to require the Company to take all necessary actions to convene a meeting of its stockholders prior to September 19, 2025, proposing stockholder approval authorizing (i) the transactions contemplated by the Note Purchase Agreement, (ii) the transactions contemplated by all other agreements, warrants, convertible promissory notes, and instruments entered into between the Company and White Lion, (iii) the issuance of all securities to White Lion, including securities in excess of the 19.99% Nasdaq Rule 5635 Exchange Cap, and (iv) any related matters under the Equity Line of Credit Agreement dated February 25, 2025, and applicable law. Failure by the Company to take such actions will constitute a material breach of the Note Purchase Agreement and entitle White Lion to liquidated damages in the amount of $400,000, payable immediately in cash. For the avoidance of doubt, provided the Company has taken the necessary actions, failure to obtain stockholder approval shall not constitute a breach or default under the Note Purchase Agreement. The original Note Purchase Agreement was filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 12, 2025. Amendment No. 1 to Common Stock Purchase Warrant. The Company and White Lion also entered into Amendment No. 1 to the Common Stock Purchase Warrant, originally dated May 6, 2025. The amendment revises the terms of the warrant to (i) clarify certain provisions regarding the exchange cap, and (ii) make conforming changes consiste
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits EXHIBIT INDEX Exhibit No. Description 10.1 Amendment No. 1 to Note Purchase Agreement, dated August 10, 2025, by and between OSR Holdings, Inc. and White Lion Capital, LLC. 10.2 Amendment No. 1 to Common Stock Purchase Warrant, dated August 10, 2025, by and between OSR Holdings, Inc. and White Lion Capital, LLC. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 20, 2025 OSR HOLDINGS, INC. By: /s/ Kuk Hyoun Hwang Name: Kuk Hyoun Hwang Title: Chief Executive Officer 2